首页> 外国专利> quinazoline derivative, pharmaceutical composition, use of a quinazoline derivative, methods to produce an anti-proliferative effect in a warm-blooded animal, to prevent or treat tumors in a warm-blooded aminal, to provide a tyrosine kinase inhibitory effect of selective egfr in a warm-blooded animal and to treat cancer in a warm-blooded animal and process for the preparation of a quinazoline derivative

quinazoline derivative, pharmaceutical composition, use of a quinazoline derivative, methods to produce an anti-proliferative effect in a warm-blooded animal, to prevent or treat tumors in a warm-blooded aminal, to provide a tyrosine kinase inhibitory effect of selective egfr in a warm-blooded animal and to treat cancer in a warm-blooded animal and process for the preparation of a quinazoline derivative

机译:喹唑啉衍生物,药物组合物,喹唑啉衍生物的用途,在温血动物中产生抗增殖作用,预防或治疗温血动物中的肿瘤,提供选择性egfr酪氨酸激酶抑制作用的方法种温血动物和治疗温血动物癌症的方法及喹唑啉衍生物的制备方法

摘要

"QUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION, USE OF A QUINAZOLINE DERIVATIVE, METHODS TO PRODUCE ANTI-PROLIFERATIVE EFFECT ON A HOT BLOOD ANIMAL, FOR PREVENTION OR TREATMENT OF TUMORS IN A FIBER BLOOD ANIMAL, AND SELECTIVE EGFR TYROSINE KINASE IN A HOT BLOOD ANIMAL AND TO TREAT A CANCER IN A HOT BLOOD ANIMAL, AND, PROCESS FOR PREPARING A QUINAZOLINE DERIVATIVE ". The invention relates to quinazoline derivatives of Formula (I) wherein each of R¬1¬, R¬2¬, W, X¬1,, X¬2¬, Z, a and b are as defined in the description; processes for their preparation; pharmaceutical compositions containing them and their use in the manufacture of a medicament for providing an antiproliferative effect. The quinazoline derivatives of Formula (I) are expected to be useful in the treatment of diseases such as certain erbB receptor tyrosine kinase-mediated cancers, particularly EGFR tyrosine kinase.
机译:“喹唑啉衍生物,药物组合物,喹唑啉衍生物的使用,对热血动物产生抗增生作用的方法,用于预防或治疗纤维血动物中的肿瘤以及选择性的EGFR酪氨酸激酶和激酶激酶在热血动物中治疗癌症,并准备喹唑啉衍生物。本发明涉及式(I)的喹唑啉衍生物,其中R 1,R 2,W,X 1,X 2,Z,a和b中的每一个如说明书中所定义。准备过程;包含它们的药物组合物及其在制备用于提供抗增殖作用的药物中的用途。预期式(I)的喹唑啉衍生物可用于治疗疾病,例如某些erbB受体酪氨酸激酶介导的癌症,特别是EGFR酪氨酸激酶。

著录项

  • 公开/公告号BRPI0414488A

    专利类型

  • 公开/公告日2006-11-14

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR2004PI14488

  • 申请日2004-09-13

  • 分类号C07D403/12;C07D401/12;C07D401/14;A61K31/517;A61P35/00;

  • 国家 BR

  • 入库时间 2022-08-21 20:59:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号